Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy
2009 · Cancer Research · 207 citations
https://doi.org/10.1158/0008-5472.can-09-1845
G
Guanglei Zhuang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
177
Papers
5.9K
Citations
41
h-index
65
i10-index
Guanglei Zhuang is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Angiogenesis and VEGF in Cancer & Ovarian cancer diagnosis and treatment & RNA modifications and cancer. The author has an h-index of 41, co-authored 151 publications.
ORCID: 0000-0001-8141-5096Papers by this author
worksNumb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation
2023 · Cell Reports · 140 citations
https://doi.org/10.1016/j.celrep.2023.112033
Metabolic and transcriptional profiling reveals pyruvate dehydrogenase kinase 4 as a mediator of epithelial-mesenchymal transition and drug resistance in tumor cells
2014 · Cancer & Metabolism · 134 citations
https://doi.org/10.1186/2049-3002-2-20
Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase
2018 · Theranostics · 103 citations
https://doi.org/10.7150/thno.23177
USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade
2021 · Nature Communications · 75 citations
https://doi.org/10.1038/s41467-021-25032-5
Comprehensive genomic profiling of neuroendocrine bladder cancer pinpoints molecular origin and potential therapeutics
2018 · Oncogene · 62 citations
https://doi.org/10.1038/s41388-018-0192-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat